Human umbilical cord mesenchymal stem cells achieve neuroprotection via exosome-mediated anti-inflammation and blood-brain barrier recovery

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Ischemia-reperfusion can aggravate cerebral damage. Mesenchymal stem cells have gained attention to improve the outcome of ischemia-reperfusion injury. This study aims to investigate the effects and mechanisms of human umbilical cord mesenchymal stem cells (hUC-MSCs) on cerebral ischemia-reperfusion injury in rats. Methods A middle cerebral artery occlusion-reperfusion (MCAO/R) model was successfully established, and hUC-MSCs or hUC-MSC-derived exosomes (hUC-MSC-exos) were injected into rats via stereotactic brain injection or the tail vein. Neurological functions were evaluated using Garcia, foot-fault, adhesive removal, and forepaw grip strength tests. In addition, we detected the expression of IL-1β, IL-10 and MMP9 in brain tissue using enzyme-linked immunosorbent assay. Immunofluorescence experiments detected the express of CD68 in the M1- microglia, the express of CD206 in the M2-microglia and the expression of Nrf2 in brain tissue. Western blotting experiments detected the expression of occludin, ZO-1, HO-1, and Nrf2 in brain tissue. Results HUC-MSCs significantly reduced the error rate and time to sense in the foot-fault test and in adhesive removal test. Similarly, hUC-MSCs can also significantly reduced infarct size and brain water content. HUC-MSCs improved morphology of brain tissue and cellular structure, including an increase in number of neurons containing Nissl bodies. And T2-weighted imaging revealed a reduction in high signal areas within the ischemic hemisphere in the cell group (hUC-MSCs). Further findings demonstrated that hUC-MSC-exos also improved neurological function and ameliorated the brain injury and morphological changes. In addition, hUC-MSC-exos decreased the contents of IL-1β, MMP-9, and the expression of CD68 (M1-microglia) r, augmented the expression of IL-10, ZO-1, Occludin, Nrf2, HO-1, and the expression of CD206 (M2-microglia). Conclusion These results indicated that human umbilical cord mesenchymal stem cells may excert neuroprotective effects in cerebral ischemia-reperfusion injury by inhibiting inflammation and protecting blood-brain barrier integrity via exosome-mediated Nrf2/HO-1 signaling pathway.

Article activity feed